Ethyl 4-hydroxypyrazolo[1,5-a]pyridine-3-carboxylate, 98%, 250mg

(R)-1-tert-Butyl 2-methyl piperidine-1,2-dicarboxylate, 95.0%, 10g

6-(Hydroxymethyl)piperidin-2-one, 97%, 100mg

(R)-Methyl morpholine-3-carboxylate hydrochloride, 95.0%, 1g

3,4-Diaminobutanoic acid dihydrochloride, 95.0%, 100mg

Tapas de cierre, Gesch. frontal, Ø 20 mm 500 uds.

Methyl 6-bromo-[1,2,4]triazolo[4,3-a]pyridine-8-carboxylate, 98%, 1g

C-(4-Methyl-[1,2,3]thiadiazol-5-yl)-methylamine, 95.0%, 1g

6-Methyl-4-pyrimidinamine, 95.0%, 10g

2-(1,4-Dioxaspiro[4.5]decan-8-yl)ethanamine, 95.0%, 1g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(2,4-dimethoxybenzyl)-L-alanine, 95%, 500mg

(R)-1-(5-Bromo-2-fluorophenyl)ethanamine hydrochloride, 98%, 100mg

3-Fluoro-5-(methoxycarbonyl)benzoic acid, 97%, 250mg